Cannara Biotech Inc
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. I… Read more
Cannara Biotech Inc (LOVFF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of November 2025: 0.072x
Based on the latest financial reports, Cannara Biotech Inc (LOVFF) has a cash flow conversion efficiency ratio of 0.072x as of November 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($7.96 Million) by net assets ($111.21 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cannara Biotech Inc - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Cannara Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Cannara Biotech Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cannara Biotech Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Openbase Inc
KQ:049480
|
0.036x |
|
Sunmow Holding Bhd
KLSE:03050
|
-0.035x |
|
MS Industrie AG
F:MSAG
|
0.082x |
|
AIFORIA TECHNOLOGIES OYJ
F:L6J
|
N/A |
|
Sumeeko Industries Co Ltd
TWO:2066
|
-0.039x |
|
CompX International Inc
NYSE MKT:CIX
|
0.087x |
|
The Beachbody Company, Inc.
NYSE:BODI
|
0.413x |
|
Intchains Group Limited American Depositary Shares
NASDAQ:ICG
|
-0.020x |
Annual Cash Flow Conversion Efficiency for Cannara Biotech Inc (2018–2025)
The table below shows the annual cash flow conversion efficiency of Cannara Biotech Inc from 2018 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-08-31 | $102.22 Million | $20.01 Million | 0.196x | +61.19% |
| 2024-08-31 | $87.95 Million | $10.68 Million | 0.121x | +78.15% |
| 2023-08-31 | $79.74 Million | $5.44 Million | 0.068x | +174.85% |
| 2022-08-31 | $66.74 Million | $-6.08 Million | -0.091x | -179.05% |
| 2021-08-31 | $64.12 Million | $-2.09 Million | -0.033x | +86.57% |
| 2020-08-31 | $38.36 Million | $-9.32 Million | -0.243x | -63.78% |
| 2019-08-31 | $49.93 Million | $-7.41 Million | -0.148x | +5.07% |
| 2018-08-31 | $14.74 Million | $-2.30 Million | -0.156x | -- |